TECNOTREE
26.2.2024 11:54:29 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, is thrilled to announce a ground-breaking partnership with BytePlus, the enterprise arm of Bytedance, to revolutionise wholesale enterprise monetization through Tecnotree Moments campaign management for CSPs. This collaboration marks a significant milestone in B2B2X digital ecosystem management, showcasing a bold step towards enhanced AI and API monetization strategies for CSPs worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226979665/en/
(Graphic: Business Wire)
Tecnotree Moments, leveraging its expertise in telco partner ecosystem monetisation, has partnered with Byteplus, in digital media and distribution, introducing cutting-edge solutions that drive value and growth for CSPs. The partnership underscores Tecnotree Moments's commitment to delivering AI solutions such as channel personalization and interactive experiences on a unified telecom led customer data platform, enabling CSPs to unlock new enterprise revenue streams through AIML and Multi-AIML model management for goal based learning delivering hyper-personalisation in video, music and ARVR advertising for the 3 dimensional 5G world.
The reseller API integration will see Tecnotree Moments reselling Byteplus’s advanced media technology on Moments’ campaign and marketplace to a ecosystem of digital services partners through CSPs. Tecnotree will be integrating wholesale advertising, content personalisation, and AIML recommendation models, to help CSPs in B2B2X enterprise monetisation across telecom, social media and digital channels. The comprehensive monetization suite, while enhancing customer experience will unlock new revenue streams for Telcos beyond data bundling, empowering CSPs to maximize revenue opportunities through Cost Per Click (CPC), Cost Per Mille (CPM) models and other cloud based subscription models for advertising.
Commenting on the partnership, Prianca Ravichander, CMO and Global Head of Partnerships of Tecnotree Corporation, said, “The 5G AI future is 3 dimensional with the digital landscape rapidly evolving, there is an opportunity to help CSPs monetize hyper-personalisation for enterprises on the Tecnotree Moments communication as a service platform. We are thrilled about the collaboration and its potential to reshape channel personalisation through telcos. By combining Tecnotree Moments’ channel personalisation platform for CSPs with Byteplus’s advanced creator tools and content recommendation technology for guaranteed uplift, we aim to empower creators, enterprises and telcos to thrive in the new digital economy.”
Charlie Sung, Global Head Partnership & Ecosystem, ByteDance and BytePlus said "Our collaboration with Tecnotree Moments represents a significant step forward in our mission to revolutionize digital monetization and our commitment to the region. Together, we look forward to empowering CSPs with innovative solutions, capitalize on the growing demand for personalization, and position ourselves for success in today’s digital economy”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
About BytePlus
Byteplus is designed to help businesses grow and improve efficiency by providing them with cutting-edge technology solutions that are powered by ByteDance's vast knowledge and expertise accumulated through serving billions of users globally. The platform offers a range of services, including personalized recommendation algorithms, AI technologies, machine learning, video and image recognition, cloud data warehouse and content delivery. With these tools, businesses can improve their customer experience, enhance their products and services, and gain a competitive edge in the market.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226979665/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom